National Institutes of Health: Cytopenia trials
The registry lists 14 Cytopenia studies with National Institutes of Health as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 5Phase 2 7No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDSRecruitingNCT05350748
- CHIP/CCUS Natural History ProtocolRecruitingNCT04102423
- Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
- BMS-986253 in Myelodysplastic SyndromesTerminatedNCT05148234Phase 1/2Results posted
- Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesCompletedNCT01789255Phase 2Results posted
- MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaCompletedNCT00462605Phase 2Results posted
- Vorinostat in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00305773Phase 2Results posted
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
- The National Myelodysplastic Syndromes (MDS) StudyCompletedNCT02775383
- Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic SyndromesCompletedNCT00104962Phase 1
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)CompletedNCT00072969Phase 2
- Tipifarnib in Treating Patients With Myelodysplastic SyndromesCompletedNCT00005845Phase 1
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARCCompletedNCT00000711Phase 1